TriSalus Life Sciences, Inc.

US$3.25As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TLSIHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (18.32%)
Div yield —
ROE —
Medical Devices
Beta (5Y) 0.51
PE TTM —
TSR TTM (31.43%)
Mkt cap US$200.1M
ROIC (69.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.39
4.24%
(76.35%)
Hold 10|9|5|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
(2.76%)
(5.32%)
(11.03%)
1.13%
Revenue$M
14.66
14.31
14.70
14.49
13.44%
8.91%
7.80%
0.76%
Peers (US$200.1M)
Cap (US$)
PE
225.2M
20.90x
193.2M
64.62x
190.4M
—
199.9M
49.40x
Capital
TTM
5Y
10Y
Leveragex
2.287
0.103
0.097
EBIT/Intx
1.022
0.936
0.634
Own earn%
(96.95)
50.34
51.89
Sh yield%
51.83
40.11
39.57
Owners
Insiders/Inst%
9.58
88.57
Short interest%
2.80
SBC / revenue%
1.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
4–13
$1 testx
—
Incr. ROIC%
21